Pericardial Disease Market
Pericardial Disease Market Size, Share & Trends Analysis Report By Type (Acute Pericarditis, Chronic Pericarditis, and Recurrent Pericarditis) By Diagnosis Method (Chest X-Ray, Cardiac MRI, Cardiac CT scan, Echocardiography, Electrocardiography, and Others) By Treatment Approach (NSAIDS Drugs, and Pericardiectomy) Forecast Period, (2026-2035)
Industry Overview
Pericardial disease market was valued at $3,525.7 million in 2025 and is projected to reach $7,682.1 million by 2035, growing at a CAGR of 8.2% during the forecast period (2026-2035). The global pericardial disease market is progressing as healthcare providers and pharmaceutical companies emphasize early diagnosis, precision treatment, and personalized care strategies. Growth is being propelled by advancements in diagnostic imaging technologies, minimally invasive treatment approaches, and the rising prevalence of cardiovascular disorders. Demand is further supported by increased awareness of pericardial conditions, expanding geriatric populations, and a growing emphasis on reducing hospitalizations through targeted therapies. As clinical guidelines increasingly stress evidence-based management, solutions for pericardial disease are becoming essential in improving patient outcomes and reducing treatment-related complications.
Market Dynamics
Rising Focus on Early and Accurate Diagnosis
Healthcare providers are increasingly adopting advanced diagnostic modalities, including echocardiography, cardiac MRI, CT scans, and electrocardiography, to accurately detect acute, chronic, and recurrent pericardial conditions. The growing availability of non-invasive imaging techniques and point-of-care diagnostic tools is enhancing detection rates and enabling timely intervention. Clinicians are prioritizing solutions that improve diagnostic precision, guide treatment planning, and minimize procedural risks. This focus on early and reliable diagnosis is a key driver shaping global market growth.
Advancements in Therapeutic Approaches
Treatment strategies for pericardial disease are evolving, with increased adoption of NSAIDs, corticosteroids, colchicine, and pericardiectomy procedures tailored to disease severity. Minimally invasive surgical techniques, coupled with improved post-operative care protocols, are enhancing patient recovery while reducing complications. Pharmaceutical companies are investing in novel therapies and drug formulations that target inflammation and recurrent disease episodes. The integration of personalized treatment regimens and evidence-based protocols is driving higher demand for advanced pericardial disease solutions.
Market Segmentation
- Based on the type, the market is segmented into acute pericarditis, chronic pericarditis, and recurrent pericarditis.
- Based on the diagnosis method, the market is segmented into chest X-ray, cardiac MRI, cardiac CT scan, echocardiography, electrocardiography, and others.
- Based on the Treatment Approach, the market is segmented into NSAIDS drugs and pericardiectomy.
Chronic Pericarditis Segment to Lead the Market with the Largest Share
The chronic pericarditis segment is expected to account for the largest share of the global pericardial disease market, driven by the prolonged nature of the condition and the need for sustained clinical management. Patients with chronic pericarditis often require long-term pharmacological therapy, repeated diagnostic monitoring, and, in advanced cases, surgical intervention such as pericardiectomy. The higher frequency of follow-up visits and imaging assessments contributes significantly to overall healthcare expenditure within this segment. Additionally, the rising incidence of post-infectious and post-cardiac injury syndromes is expanding the chronic patient pool. As clinicians increasingly focus on preventing disease progression and recurrence, demand for comprehensive treatment and monitoring solutions continues to reinforce this segment’s dominant market position.
Cardiac CT Scan: A Key Segment in Market Growth
Cardiac CT scanning is emerging as a critical diagnostic segment in the global pericardial disease market due to its ability to deliver high-resolution anatomical detail of the pericardium. The modality is particularly valuable in detecting pericardial thickening, calcification, and constrictive pathology, where precise structural assessment is essential for treatment planning. Growing availability of advanced CT systems, coupled with reduced scan times and improved radiation dose management, is supporting wider clinical adoption. Cardiac CT also complements echocardiography and MRI by providing rapid, accurate evaluation in complex or inconclusive cases. As diagnostic accuracy becomes central to effective pericardial disease management, the role of cardiac CT continues to expand, supporting sustained growth of this segment.
Regional Outlook
The global pericardial disease market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Strengthening Cardiac Care Infrastructure Across Europe
Europe is witnessing steady growth in the global pericardial disease market, supported by well-developed healthcare systems and increasing emphasis on advanced cardiovascular diagnostics and treatment protocols. Hospitals and cardiac care centers across the region are progressively adopting sophisticated imaging technologies, including cardiac MRI and CT scans, to improve diagnostic accuracy for pericardial conditions. Ongoing investments in healthcare infrastructure and cross-border clinical research initiatives are enhancing standardization of treatment approaches. In addition, strong regulatory oversight and adherence to evidence-based clinical guidelines are encouraging the use of validated therapeutic strategies for both acute and chronic pericardial disease. With rising awareness and improved access to specialized cardiac care, Europe continues to strengthen its position as a key regional market.
North America Region Dominates the Market with Major Share
North America holds a dominant share of the global pericardial disease market, driven by the high prevalence of cardiovascular disorders and widespread access to advanced diagnostic and treatment facilities. The region benefits from early adoption of innovative imaging modalities, minimally invasive surgical techniques, and targeted pharmacological therapies. Strong collaboration between healthcare providers, medical device manufacturers, and pharmaceutical companies is accelerating the integration of advanced pericardial disease management solutions. Additionally, favorable reimbursement frameworks and well-established clinical pathways support timely diagnosis and long-term disease management. Regulatory emphasis on early intervention and outcome-driven care further reinforces North America’s leadership in the global market.
Market Players Outlook
The major companies operating in the global pericardial disease market include AbbVie Inc., Amgen Inc., Bayer AG, Johnson & Johnson Services, Inc., Pfizer Inc., among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In July 2025, CardioThera announced the launch of PeriGuard, an innovative biologic therapy aimed at reducing recurrent pericarditis episodes in high-risk patients, marking a significant advancement in targeted therapeutic options.
- In May 2025, Siemens Healthineers expanded its cardiac imaging portfolio with the introduction of a high-resolution pericardial MRI module, designed to provide precise visualization of pericardial inflammation and effusion, enhancing early diagnosis and treatment planning.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global pericardial disease Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Pericardial Disease Market Sales Analysis – Type | Diagnosis Method | Treatment Approach ($ Million)
- Pericardial Disease Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Pericardial Disease Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Pericardial Disease Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Pericardial Disease Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Pericardial Disease Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Pericardial Disease Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Pericardial Disease Market Revenue and Share by Manufacturers
- Pericardial Disease Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- AbbVie Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Amgen Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Bayer AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Johnson & Johnson Services, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Pfizer Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- AbbVie Inc.
- Key Company Analysis
- Global Pericardial Disease Market Sales Analysis by Type ($ Million)
- Acute Pericarditis
- Chronic Pericarditis
- Recurrent Pericarditis
- Global Pericardial Disease Market Sales Analysis by Diagnosis Method ($ Million)
- Chest X-Ray
- Cardiac MRI
- Cardiac CT Scan
- Echocardiography
- Electrocardiography
- Others
- Global Pericardial Disease Market Sales Analysis by Treatment Approach ($ Million)
- NSAIDS Drugs
- Pericardiectomy
- Regional Analysis
- North American Pericardial Disease Market Sales Analysis – Type | Diagnosis Method | Treatment Approach | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Pericardial Disease Market Sales Analysis – Type | Diagnosis Method | Treatment Approach | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Pericardial Disease Market Sales Analysis – Type | Diagnosis Method | Treatment Approach | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Pericardial Disease Market Sales Analysis – Type | Diagnosis Method | Treatment Approach | Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- AbbVie Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Amgen Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- AstraZeneca plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bayer AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bristol?Myers Squibb Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cardiol Therapeutics Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cipla Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Reddy’s Laboratories Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eli Lilly and Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GE Healthcare
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hikma Pharmaceuticals PLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Johnson & Johnson Services, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Kiniksa Pharmaceuticals, Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Novartis AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pfizer Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Philips Healthcare
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sanofi S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Siemens Healthineers AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sun Pharmaceutical Industries Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Takeda Pharmaceutical Company Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- AbbVie Inc.
1. Global Pericardial Disease Market Research and Analysis by Type, 2025–2035 ($ Million)
2. Global Acute Pericarditis Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Chronic Pericarditis Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Recurrent Pericarditis Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Pericardial Disease Market Research and Analysis by Diagnosis Method, 2025–2035 ($ Million)
6. Global Chest X-Ray Pericardial Disease Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Cardiac MRI Pericardial Disease Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Cardiac CT Scan Pericardial Disease Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Echocardiography Pericardial Disease Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Electrocardiography Pericardial Disease Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Other Pericardial Disease Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Pericardial Disease Market Research and Analysis by Treatment Approach, 2025–2035 ($ Million)
13. Global NSAIDs Drugs Pericardial Disease Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global Pericardiectomy Pericardial Disease Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Global Pericardial Disease Market Research and Analysis by Region, 2025–2035 ($ Million)
16. North American Pericardial Disease Market Research and Analysis by Country, 2025–2035 ($ Million)
17. North American Pericardial Disease Market Research and Analysis by Type, 2025–2035 ($ Million)
18. North American Pericardial Disease Market Research and Analysis by Diagnosis Method, 2025–2035 ($ Million)
19. North American Pericardial Disease Market Research and Analysis by Treatment Approach, 2025–2035 ($ Million)
20. European Pericardial Disease Market Research and Analysis by Country, 2025–2035 ($ Million)
21. European Pericardial Disease Market Research and Analysis by Type, 2025–2035 ($ Million)
22. European Pericardial Disease Market Research and Analysis by Diagnosis Method, 2025–2035 ($ Million)
23. European Pericardial Disease Market Research and Analysis by Treatment Approach, 2025–2035 ($ Million)
24. Asia-Pacific Pericardial Disease Market Research and Analysis by Country, 2025–2035 ($ Million)
25. Asia-Pacific Pericardial Disease Market Research and Analysis by Type, 2025–2035 ($ Million)
26. Asia-Pacific Pericardial Disease Market Research and Analysis by Diagnosis Method, 2025–2035 ($ Million)
27. Asia-Pacific Pericardial Disease Market Research and Analysis by Treatment Approach, 2025–2035 ($ Million)
28. Rest of the World Pericardial Disease Market Research and Analysis by Region, 2025–2035 ($ Million)
29. Rest of the World Pericardial Disease Market Research and Analysis by Type, 2025–2035 ($ Million)
30. Rest of the World Pericardial Disease Market Research and Analysis by Diagnosis Method, 2025–2035 ($ Million)
31. Rest of the World Pericardial Disease Market Research and Analysis by Treatment Approach, 2025–2035 ($ Million)
1. Global Pericardial Disease Market Share by Type, 2025 Vs 2035 (%)
2. Global Acute Pericarditis Market Share by Region, 2025 Vs 2035 (%)
3. Global Chronic Pericarditis Market Share by Region, 2025 Vs 2035 (%)
4. Global Recurrent Pericarditis Market Share by Region, 2025 Vs 2035 (%)
5. Global Pericardial Disease Market Share by Diagnosis Method, 2025 Vs 2035 (%)
6. Global Chest X-Ray Pericardial Disease Market Share by Region, 2025 Vs 2035 (%)
7. Global Cardiac MRI Pericardial Disease Market Share by Region, 2025 Vs 2035 (%)
8. Global Cardiac CT Scan Pericardial Disease Market Share by Region, 2025 Vs 2035 (%)
9. Global Echocardiography Pericardial Disease Market Share by Region, 2025 Vs 2035 (%)
10. Global Electrocardiography Pericardial Disease Market Share by Region, 2025 Vs 2035 (%)
11. Global Other Pericardial Disease Market Share by Region, 2025 Vs 2035 (%)
12. Global Pericardial Disease Market Share by Treatment Approach, 2025 Vs 2035 (%)
13. Global NSAIDs Drugs Pericardial Disease Market Share by Region, 2025 Vs 2035 (%)
14. Global Pericardiectomy Pericardial Disease Market Share by Region, 2025 Vs 2035 (%)
15. Global Pericardial Disease Market Research and Analysis by Region, 2025–2035 ($ Million)
16. US Pericardial Disease Market Size, 2025–2035 ($ Million)
17. Canada Pericardial Disease Market Size, 2025–2035 ($ Million)
18. UK Pericardial Disease Market Size, 2025–2035 ($ Million)
19. France Pericardial Disease Market Size, 2025–2035 ($ Million)
20. Germany Pericardial Disease Market Size, 2025–2035 ($ Million)
21. Italy Pericardial Disease Market Size, 2025–2035 ($ Million)
22. Spain Pericardial Disease Market Size, 2025–2035 ($ Million)
23. Russia Pericardial Disease Market Size, 2025–2035 ($ Million)
24. Rest of Europe Pericardial Disease Market Size, 2025–2035 ($ Million)
25. India Pericardial Disease Market Size, 2025–2035 ($ Million)
26. China Pericardial Disease Market Size, 2025–2035 ($ Million)
27. Japan Pericardial Disease Market Size, 2025–2035 ($ Million)
28. South Korea Pericardial Disease Market Size, 2025–2035 ($ Million)
29. Australia and New Zealand Pericardial Disease Market Size, 2025–2035 ($ Million)
30. ASEAN Economies Pericardial Disease Market Size, 2025–2035 ($ Million)
31. Rest of Asia-Pacific Pericardial Disease Market Size, 2025–2035 ($ Million)
32. Latin America Pericardial Disease Market Size, 2025–2035 ($ Million)
33. Middle East and Africa Pericardial Disease Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Pericardial Disease Market in 2025 is estimated to be around $3,525.7 million.
North America holds the largest share in the Pericardial Disease Market.
Leading players in the Pericardial Disease Market include AbbVie Inc., Amgen Inc., Bayer AG, Johnson & Johnson Services, Inc., Pfizer Inc., among others.
The Pericardial Disease Market is expected to grow at a CAGR of 8.2% from 2026 to 2035.
The Pericardial Disease Market growth is driven by increasing prevalence of cardiovascular disorders and rising demand for advanced diagnostic and therapeutic treatment options.
